Wikidata

(Q61938870)

English

To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

clinical trial

In more languages

Statements

title
A Phase I, Multi-center, Open-label, Single Dose Study, to Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients With or Without Renal Impairment (English)
0 references
sponsor
AstraZeneca
0 references
main subject
diabetes
0 references
start time
March 2010
0 references
end time
October 2010
0 references
number of participants
21
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61938870&oldid=2111700115"